ADDvise Group B — Capital/Financing Update 2023

May 4, 2023

ADDvise

PRESS RELEASE

Stockholm May 4, 2023

ADDvise Group contemplates issuance of new senior secured bonds and redemption of its existing bonds

Further to recent communication, ADDvise Group AB (publ) ("ADDvise") has mandated Pareto Securities AB and Skandinaviska Enskilda Banken AB (publ) to arrange a series of fixed income investor meetings starting on 8 May 2023. Subject to inter alia market conditions, a senior secured bond issue in an expected amount of SEK 1 billion and with a tenor of three years may follow (the "Bond Issue").

The proceeds from the Bond Issue will be used to refinance existing debt and to finance general corporate purposes including acquisitions. Accordingly, subject to a successful Bond Issue, ADDvise contemplates to redeem its existing bonds of SEK 650 million with ISIN SE0015222088 at the applicable redemption premium.

For further information, please contact:

Rikard Akhtarzand, CEO

+46 765-25 90 71

rikard.akhtarzand@addvisegroup.se

Hanna Myhrman, General Counsel

+46 709-82 92 23

hanna.myhrman@addvisegroup.se

About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The Group consists of two business units: Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expanding the business—both geographically and product-wise. ADDvise Group's shares are listed on Nasdaq First North Premier Growth Market, and Mangold Fondkommission AB, +46 (0)8-503 015 50, CA@mangold.se, is the company's certified adviser. Further information is available at www.addvisegroup.com.

Sid 1/1